Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship Program | DuchenneXchange

welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship Program


Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, today announced that the website for Route 79, The Duchenne Scholarship Program, is officially open and accepting applications. Academic scholarships of up to $5,000 will be awarded to up to 20 individuals chosen by an independent committee of Duchenne community members based on an applicant’s community involvement and personal essay. The Route 79 program is designed to help students with Duchenne pursue their post-secondary educational goals.

“In 2018, we launched Route 79, The Duchenne Scholarship Program, supporting the educational goals of students living with Duchenne,” said Douglas Ingram, Sarepta’s president and chief executive officer. “The response to Route 79 has been overwhelming and the quality of applications from our first year of the program was very impressive.  Once again this year we are excited to receive and evaluate applications from ambitious students who would benefit from Route 79.”

Sarepta Therapeutics Announces Second Year Of Route 79, The Duchenne Scholarship Program

rareRelated